4//SEC Filing
Panzara Michael A. 4
Accession 0000899243-19-019395
CIK 0001631574other
Filed
Jul 8, 8:00 PM ET
Accepted
Jul 9, 6:11 PM ET
Size
7.1 KB
Accession
0000899243-19-019395
Insider Transaction Report
Form 4
Panzara Michael A.
Franchise Lead, Neurology
Transactions
- Sale
Ordinary Shares
2019-07-05$27.26/sh−445$12,131→ 42,330 total - Sale
Ordinary Shares
2019-07-05$26.88/sh−2,613$70,237→ 42,775 total
Footnotes (2)
- [F1]Consists of sale of restricted share units (RSUs) effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 17, 2019.
- [F2]The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $26.25 to $27.21 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
Documents
Issuer
Wave Life Sciences Ltd.
CIK 0001631574
Entity typeother
Related Parties
1- filerCIK 0001679039
Filing Metadata
- Form type
- 4
- Filed
- Jul 8, 8:00 PM ET
- Accepted
- Jul 9, 6:11 PM ET
- Size
- 7.1 KB